Art

J-GLOBAL ID：201802239747948941   Reference number：18A1487668

Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia

ホモ接合HLA-C1は骨髄性白血病患者におけるHLA適合移植後の再発リスク低下と関連する【JST・京大機械翻訳】

Author (21)： Arima Nobuyoshi (Department of Hematology, Medical Research Institute Kitano Hospital, Osaka, Japan) ,  Kanda Junya (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Tanaka Junji (Department of Hematology, Tokyo Women’s Medical University, Tokyo, Japan) ,  Yabe Toshio (Hematology Division, Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan) ,  Morishima Yasuo (Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan) ,  Kim Sung-Won (Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan) ,  Najima Yuho (Hematology Division, Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan) ,  Ozawa Yukiyasu (Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan) ,  Eto Tetsuya (Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan) ,  Kanamori Heiwa (Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan) ,  Mori Takehiko (Department of Hematology, Keio University School of Medicine, Tokyo, Japan) ,  Kobayashi Naoki (Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan) ,  Kondo Tadakazu (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Nakamae Hirohisa (Department of Hematology, Osaka City University Hospital, Osaka, Japan) ,  Uchida Naoyuki (Department of Hematology, Toranomon Hospital, Tokyo, Japan) ,  Inoue Masami (Department of Hematology/Oncology, Osaka Women’s and Children’s Hospital, Osaka, Japan) ,  Fukuda Takahiro (Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan) ,  Ichinohe Tatsuo (Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan) ,  Atsuta Yoshiko (Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan) ,  Atsuta Yoshiko (Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Kanda Yoshinobu (Devision of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan)
Material： Biology of Blood and Marrow Transplantation  (Biol Blood Marrow Transplant)
Volume： 24  Issue： 4  Page： 717-725  Publication year： 2018 
JST Material Number： W1625A  ISSN： 1083-8791  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Natural killer (NK) cells assu...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1487668&from=J-GLOBAL&jstjournalNo=W1625A") }}

Thesaurus term： *patient ,  *Leukemia ,  lymphoma ,  hematopoietic stem cell transplantation ,  donor ,  receptor ,  Japan ,  NK cell ,  allele ,  immunoglobulin ,  graft ,  acute myeloid leukemia ,  child ,  donor ,  *HLA-C Antigens ,  *HLA matching

Author keywords (5)： Allogeneic hematopoietic stem cell transplantation ,  Natural killer cell ,  Killer cell immunoglobulin-like receptor ,  HLA-C ,  Graft-versus-leukemia

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Transplantation immunity  (ED03020E)

Terms in the title (6)： ホモ接合 ,  骨髄性白血病 ,  患者 ,  HLA適合 ,  移植 ,  再発リスク